Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis

American Journal of Cardiology

Volumn 112, Issue 4, 2013, Pages 574-579

  Ben Dor, Itsik ^a   Minha, Sa'Ar ^a   Barbash, Israel M ^a   Aly, Omar ^a   Dvir, Danny ^a   Deksissa, Teshome ^a   Okubagzi, Petros ^a   Torguson, Rebecca ^a   Lindsay, Joseph ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN;

AGED; AORTA STENOSIS; AORTIC VALVE REPAIR; ARTICLE; COHORT ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART OUTPUT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84881160989     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.04.023     Document Type: Article

References (16)

1. I. Ben-Dor, A.D. Pichard, L.F. Satler, S.A. Goldstein, A.I. Syed, M.A. Gaglia Jr., G. Weissman, G. Maluenda, M.A. Gonzalez, K. Wakabayashi, S.D. Collins, R. Torguson, P. Okubagzi, Z. Xue, K.M. Kent, J. Lindsay, and R. Waksman Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients JACC Cardiovasc Interv 3 2010 1150 1156
2. P. Lim, J.L. Monin, M. Monchi, J. Garot, A. Pasquet, L. Hittinger, J.L. Vanoverschelde, A. Carayon, and P. Gueret Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide Eur Heart J 25 2004 2048 2053
3. M.G. Nessmith, H. Fukuta, S. Brucks, and W.C. Little Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery Am J Cardiol 96 2005 1445 1448
4. M. Katz, F. Tarasoutchi, A.E. Pesaro, R.D. Lopes, G.S. Spina, M.L. Vieira, and M. Grinberg Natriuretic peptides and long-term mortality in patients with severe aortic stenosis J Heart Valve Dis 21 2012 331 336
5. J. Bergler-Klein, U. Klaar, M. Heger, R. Rosenhek, G. Mundigler, H. Gabriel, T. Binder, R. Pacher, G. Maurer, and H. Baumgartner Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308
6. R. Pfister, T. Wahlers, F.M. Baer, M. Scherner, J. Strauch, and E. Erdmann Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement Clin Res Cardiol 99 2010 301 307
7. M. Weber, R. Arnold, M. Rau, R. Brandt, A. Berkovitsch, V. Mitrovic, and C. Hamm Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis Am J Cardiol 94 2004 740 745
8. M. Weber, R. Arnold, M. Rau, A. Elsaesser, R. Brandt, V. Mitrovic, and C. Hamm Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease Eur Heart J 26 2005 1023 1030
9. R. Dworakowski, O. Wendler, A. Bhan, L. Smith, P. Pearson, E. Alcock, K. Rajagopal, B. Brickham, T. Dew, J. Byrne, M.J. Monaghan, R. Sherwood, A.M. Shah, and P.A. Maccarthy Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction Heart 98 2012 1641 1646
10. K. Spargias, S. Polymeros, A. Dimopoulos, A. Manginas, G. Pavlides, M. Balanika, A. Smirli, G. Stavridis, G. Dangas, and D.V. Cokkinos The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation J Interv Cardiol 24 2011 462 469
11. G. Kostopanagiotou, E. Apostolakis, K. Theodoraki, D. Rizos, C. Pantos, E. Kastellanos, and V. Smyrniotis Perioperative changes in atrial natriuretic peptide plasma levels associated with mitral and aortic valve replacement J Cardiothorac Vasc Anesth 18 2004 30 33
12. A. Georges, F. Forestier, N. Valli, A. Plogin, G. Janvier, and L. Bordenave Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement Eur J Cardiothorac Surg 25 2004 941 945
13. W. Qi, P. Mathisen, J. Kjekshus, S. Simonsen, K. Endresen, R. Bjørnerheim, and C. Hall The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis Clin Cardiol 25 2002 174 180
14. N.O. Neverdal, C.W. Knudsen, T. Husebye, O.A. Vengen, J. Pepper, M. Lie, and T. Tønnessen The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year follow-up Eur J Heart Fail 8 2006 257 262
15. C.M. Otto, M.C. Mickel, J.W. Kennedy, E.L. Alderman, T.M. Bashore, P.C. Block, J.A. Brinker, D. Diver, J. Ferguson, and D.R. Holmes Jr. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis Circulation 89 1994 642 650
16. K. Spargias, E. Alexopoulos, S. Thomopoulou, A. Dimopoulos, A. Manginas, G. Pavlides, V. Voudris, G. Karatassakis, G. Athanassopoulos, and D.V. Cokkinos Effect of balloon valvuloplasty in patients with severe aortic stenosis on levels of N-terminal pro-B-type natriuretic peptide Am J Cardiol 104 2009 846 849